These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea. Song H; Koh Y; Rhee TM; Choi SY; Kang S; Lee SP Atherosclerosis; 2022 May; 348():16-24. PubMed ID: 35390551 [TBL] [Abstract][Full Text] [Related]
8. Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry. Breedon JR; Marshall CR; Giovannoni G; van Heel DA; ; Dobson R; Jacobs BM Brain Commun; 2023; 5(2):fcad041. PubMed ID: 37006331 [TBL] [Abstract][Full Text] [Related]
10. The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives. Cupido AJ; Tromp TR; Hovingh GK Curr Opin Lipidol; 2021 Apr; 32(2):112-116. PubMed ID: 33560669 [TBL] [Abstract][Full Text] [Related]
11. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia. Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425 [TBL] [Abstract][Full Text] [Related]
12. Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia. Sarraju A; Knowles JW Front Cardiovasc Med; 2019; 6():5. PubMed ID: 30761309 [TBL] [Abstract][Full Text] [Related]
13. Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains. Wurst C; Maixner F; Paladin A; Mussauer A; Valverde G; Narula J; Thompson R; Zink A Ann Glob Health; 2024; 90(1):6. PubMed ID: 38273870 [TBL] [Abstract][Full Text] [Related]
14. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476 [TBL] [Abstract][Full Text] [Related]
15. Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist. Belanger MJ; Kelly EM; Tahir UA; Benson MD Cardiol Rev; 2022 Jul-Aug 01; 30(4):206-213. PubMed ID: 33758125 [TBL] [Abstract][Full Text] [Related]
16. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017 [TBL] [Abstract][Full Text] [Related]
17. Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor. Jarauta E; Bea-Sanz AM; Marco-Benedi V; Lamiquiz-Moneo I Front Genet; 2020; 11():554931. PubMed ID: 33343620 [TBL] [Abstract][Full Text] [Related]
18. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members. Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Roberts MR; Asgari MM; Toland AE Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599 [TBL] [Abstract][Full Text] [Related]
20. Perspective: The Clinical Use of Polygenic Risk Scores: Race, Ethnicity, and Health Disparities. Roberts MC; Khoury MJ; Mensah GA Ethn Dis; 2019; 29(3):513-516. PubMed ID: 31367172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]